Sage Therapeutics Inc. buy Needham & Company LLC
Start price
07.08.23
/
50%
€17.80
Target price
07.08.24
€63.64
Performance (%)
-57.02%
End price
08.08.24
€7.65
Summary
This prediction ended on 08.08.24 with a price of €7.65. The BUY prediction by Needham___Company_LL for Sage Therapeutics Inc. performed very badly with a performance of -57.02%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by Needham___Company_LL for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $70.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten